FDA Approved Products

Application #TypeSponsorNotesProduct #Drug NameFormStrengthActive IngredientApproval DateMarketing StatusReference Standard
218710NDAPHATHOM PHARMACEUTICALS INC001VOQUEZNATABLET; ORALEQ 10MG BASEVONOPRAZAN FUMARATE2024-07-17PrescriptionNo
002VOQUEZNATABLET; ORALEQ 20MG BASEVONOPRAZAN FUMARATE2024-07-17PrescriptionNo
215151NDAPHATHOM001VOQUEZNATABLET;ORALEQ 10MG BASEVONOPRAZAN FUMARATE2023-11-01PrescriptionNo
002VOQUEZNATABLET;ORALEQ 20MG BASEVONOPRAZAN FUMARATE2023-11-01PrescriptionYes
215152NDAPHATHOM001VOQUEZNA TRIPLE PAKCAPSULE, TABLET, TABLET;ORAL500MG;500MG;EQ 20MG BASEAMOXICILLIN; CLARITHROMYCIN; VONOPRAZAN FUMARATE2022-05-03PrescriptionYes
215153NDAPHATHOM001VOQUEZNA DUAL PAKCAPSULE, TABLET;ORAL500MG;EQ 20MG BASEAMOXICILLIN; VONOPRAZAN FUMARATE2022-05-03PrescriptionYes